A new class of C:G to G:C base editors have been developed by researchers from Singapore. The base editors consist of a nickase-Cas9 fused to a cytidine deaminase and base excision repair proteins, and they target cytidine in WCW, ACC or GCT sequence contexts with a mean efficiency of 15.4% without selection.
A new set of tools have been established to standardise phage host prediction based on CRISPR spacers. The researchers from Université Laval in Québec City, Canada, will use the approach to discover as yet unknown phages and demonstrated their use for the identification of phages that infect gut-associated bacteria.
Cellectisannounced in a quarterly business update and financial report a cash position of $274 million as of the beginning of the year and a cash runway into late 2022. Three Cellectis-sponsored phase 1 clinical trials are ongoing, and a new collaboration with Cytovia Therapeutics to develop TALEN gene-edited iPSC-derived NK and CAR NK cell programs.
"Precision Engineering of the Genome, Epigenome and Transcriptome" is the title of a Virtual Keystone Symposia taking place 8-10 March. You can register for the event here.
The New York Academy of Sciences has arranged a webinar entitled CRISPR: New Frontiers for 15 March. You can register for the webinar here.
CRISPR has been used for knockout of the asparagine synthetase gene, TaASN2, of wheat. The feat yielded grains with 90% reduced levels of free asparagine. Free asparagine is the precursor for acrylamide - a suspected carcinogen - which forms during the baking, toasting and high‐temperature processing of foods made from wheat.